Invention Grant
- Patent Title: Oxopiperazine derivatives
-
Application No.: US17570959Application Date: 2022-01-07
-
Publication No.: US12012393B2Publication Date: 2024-06-18
- Inventor: Marc Labelle , Ulrich Kessler , Valentino Cattori , Cyril Cook , Ramkrishna Reddy Vakiti , Kevin R. D. Johnson , Matinder Kaur , Jean-d'amour K. Twibanire , Farman Ullah
- Applicant: Inthera Bioscience AG
- Applicant Address: CH Wadenswil
- Assignee: Inthera Bioscience AG
- Current Assignee: Inthera Bioscience AG
- Current Assignee Address: CH Zurich
- Agency: COOLEY LLP
- Agent Heidi A. Erlacher; Christine E. Dunne
- Priority: CH 15218 2018.02.08
- The original application number of the division: US16222479 2018.12.17
- Main IPC: C07D401/06
- IPC: C07D401/06 ; A61K45/06 ; A61P35/00 ; A61P35/02 ; C07D401/14 ; C07D471/04 ; C07D471/10 ; C07D491/107 ; C07D491/113 ; C07D491/20 ; C07D495/04 ; C07D495/10 ; C07D497/10
Abstract:
The present invention relates to novel compounds of formula (I) or formula (Ia)
pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
Public/Granted literature
- US20220213057A1 OXOPIPERAZINE DERIVATIVES Public/Granted day:2022-07-07
Information query
